Clinical and Experimental Pharmacology and Physiology · 2021 · 19 citations · 21 references
MedicineOncologyPharmacologyCell SignalingMetastasisMolecular OncologyAngiogenesis In CancerCancer Cell SignalingMalignant NeoplasmsTumor Microenvironment ModulationCellular ChemotaxisChemotaxisNon-small Cell Lung Cancer TherapyPretreatmentWestern Blotting
Vasculogenic mimicry (VM) is associated with aggressive cancer cells. Salvianolic acid A (Sal-A), an antioxidant and anti-inflammatory agent, has bioactive properties from Salvia miltiorrhiza Bunge. Current investigation aspired to explore the activity of Sal-A in the VM formation of non-small cell lung cancer (NSCLC) and the mechanism underling this function. The CCK8, the scratch and boyden chemotaxis assay were presented to describe NSCLC cells viability, migration and invasion capabilities, respectively. The protein expression was verified by western blotting. In this report, Sal-A caused a reduction in viability, metastasis and capillaries structure formation of NSCLC cells. Additionally, Sal-A markedly prevented the key VM related proteins, containing EphA2, VE-cadherin and MMP2. Besides, Sal-A significantly diminished p-PI3K, p-Akt and p-mTOR level in NSCLC cells. More importantly, SC79 pretreatment reversed Sal-A inhibits NSCLC cells viability, metastasis and VM formation. These data exhibit that Sal-A could block VM network formation in NSCLC cells through modulating the PI3K/Akt/mTOR signalling pathway.
21
RETRACTED ARTICLE: Vasculogenic mimicry formation in EBV-associated epithelial malignancies
Tong Xiang, Yu-Xin Lin, Wenlong Ma et al. · Nature Communications · 2018 · 174 citations · Full text
Medicine, Cancer Biology, Oncology +17
Rong Wang, Fuxing Song, Shengnan Li et al. · Drug Design Development and Therapy · 2019 · 159 citations · Full text
Medicine, Biochemistry, Pharmacology +14
Haofan Wang, Shasha Wang, Min Zheng et al. · Cell Proliferation · 2019 · 114 citations · Full text
Medicine, Cancer Biology, Oncology +17
Fang Li, Yu Wang, Weiliang Chen et al. · Theranostics · 2019 · 102 citations · Full text
Pharmacy, Oncology, Pharmaceutics +17